Private addiction and dual diagnosis treatment center Annandale Behavioral Health develops a comprehensive continuum of care for drug and alcohol recovery.
PASADENA, CA / ACCESSWIRE / January 17, 2024 / Annandale Behavioral Health has unveiled an updated and expanded residential addiction recovery program to coincide with its brand new name. First opening its doors in 2020 as Elevate Wellness Center, the private Pasadena rehab got its initial footing while serving individuals in need of drug and/or alcohol detox and addiction treatment during the Covid-19 outbreak.
Over the ensuing years, it has evolved into a robust clinical program that provides the full continuum of care for individuals who reside locally, nationally, or abroad. “This led us to rethink our brand,” states Program Director Remy Olivier, RN. “We are very proud of the work we accomplished as Elevate Wellness Center, but feel Annandale Behavioral Health is a better representation of the serious work we provide for our clients.”
Annandale Behavioral Health provides life-changing treatment for individuals battling substance use disorder and co-occurring mental health challenges. The expert team includes top-tier physicians, psychiatrists, therapists, nursing and support staff. Treatment elements feature a curated tapestry of evidence-based modalities, including:
Nestled in the tranquil backdrop of quaint Pasadena, California, Annandale Behavioral Health seeks to be a supportive safe haven for individuals seeking long-term sobriety and wellness. States Olivier, “We’re excited to continue implementing additional services over time to accommodate the evolving needs of the people we help.”
Annandale Behavioral Health is a residential addiction treatment center located in lovely Pasadena, CA. Its multidisciplinary team offers the full continuum of care within a supportive and respectful setting, providing the ideal environment for achieving both sobriety and personal growth.
Contact Information
Remy Olivier
RN, Founder, and Program Director
info@annandalebh.com
(855) 778-8668
SOURCE: Annandale Behavioral Health
View the original press release on newswire.com.
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…
Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…
